Efficacy and Safety Study to Evaluate Vadadustat for the Correction of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Completed
Akebia Therapeutics
Phase 3
A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction of
anemia and maintenance of hemoglobin (Hb) in subjects with NDD-CKD
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Completed
Akebia Therapeutics
Phase 3
A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance
treatment of anemia in subjects with NDD-CKD
Efficacy and Safety Study to Evaluate Vadadustat for the Correction or Maintenance Treatment of Anemia in Subjects With Incident Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Completed
Akebia Therapeutics
Phase 3
A multicenter, randomized, open-label, active-controlled Phase 3 study for the correction or
maintenance treatment of anemia in subjects with incident DD-CKD.
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-dependent Chronic Kidney Disease (DD-CKD)
Completed
Akebia Therapeutics
Phase 3
A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance
treatment of anemia in subjects with DD-CKD
Dose-Finding Study of Vadadustat in Japanese Subjects With Anemia Secondary to Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD)
Completed
Akebia Therapeutics
Phase 2
This is a Phase 2, randomized, double-blind, placebo-controlled, dose-finding study to assess
the efficacy, safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) of orally
administered vadadustat in Japanese participants with anemia secondary to Non-dialysis
Dependent Chronic Kidney Disease (NDD-CKD).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
